Description
In October 2025 the European Patent Office implemented significant changes to colored drawings, abandoning its requirement of only accepting drawings without coloring. This is a shift that is being seen around jurisdictions globally. More and more patent offices around the world are recognizing the importance of colored drawings in patent applications.
The colored drawings effectively express essential details in utility patent applications across a variety of categories and design patent applications. Global drawing strategy should be set at the priority stage and carried out through prosecution to preserve disclosure integrity, minimize conversion risk, and maintain consistent support across jurisdictions with divergent color practices.
Listen as our panel of experienced patent attorneys examines the evolving patent illustration landscape. The panel will review key jurisdictions and discuss what companies and counsel need to consider when filing, the differences between the type of patent being filed, and best practices for leveraging these changes.
Presented By
For over 25 years, Ms. Mueller has provided strategic counsel on complex patent issues to clients in the pharmaceutical, biopharmaceutical, biotechnology, and chemistry sectors. She brings in-depth knowledge and extensive experience to her work, advising clients on the global patent protection, freedom to operate, and validity of blockbuster drugs they aim to produce and distribute. With a background in chemistry and biology, Ms. Mueller provides advice on the full spectrum of global intellectual property portfolio management, including patent prosecution, opposition, and other post-grant proceedings, and diverse regulatory matters. Since 2001, she has worked closely with in-house legal departments of global pharmaceutical firms regarding their patent development and enforcement strategies. In this partnership, Ms. Mueller provides training to new in-house counsel. She meets with scientists and other business development to anticipate and resolve a wide array of problems, including navigation of FDA approval. A thought leader on pharmaceutical and biopharmaceutical patent law, Ms. Mueller frequently speaks to legal and industry groups and publishes widely.
-
This 90-minute webinar is eligible in most states for 1.5 CLE credits.
-
Date + Time
- event
Thursday, January 8, 2026
- schedule
1:00 p.m. ET./10:00 a.m. PT
I. Patent illustration trends
II. EPO and other changes in key jurisdictions
III. PCT practices and implications
IV. Best practices
The panel will review these and other important issues:
- How can applicants take advantage of jurisdictions where color drawings are required without hurting applications that require non-colored drawings?
- What steps should counsel take to manage continuations and divisionals so later claims can rely on the embodiments?
- What implications do changes to colored drawing have for PCT practice?
Related Courses
Patent Drawings: Navigating the Evolving Global Colored Drawing Requirements Landscape
Thursday, January 8, 2026
1:00 p.m. ET./10:00 a.m. PT
